Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neuropeptide Y Receptor Type 2 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neuropeptide Y Receptor Type 2market, defines the market attractiveness level of Neuropeptide Y Receptor Type 2 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neuropeptide Y Receptor Type 2 industry, describes the types of Neuropeptide Y Receptor Type 2 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neuropeptide Y Receptor Type 2 market and the development prospects and opportunities of Neuropeptide Y Receptor Type 2 industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neuropeptide Y Receptor Type 2 market in Chapter 13.
By Player:
XL-protein GmbH
Gila Therapeutics Inc
Novo Nordisk A/S
By Type:
XL-310
NN-9748
GT-002
Others
By End-User:
Obesity
Epilepsy
Diabetes
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neuropeptide Y Receptor Type 2 Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neuropeptide Y Receptor Type 2 Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neuropeptide Y Receptor Type 2 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neuropeptide Y Receptor Type 2 Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neuropeptide Y Receptor Type 2 Market Analysis and Outlook to 2022
-
7.1 Global Neuropeptide Y Receptor Type 2 Consumption (2017-2022)
-
7.2 United States Neuropeptide Y Receptor Type 2 Consumption (2017-2022)
-
7.3 Europe Neuropeptide Y Receptor Type 2 Consumption (2017-2022)
-
7.4 China Neuropeptide Y Receptor Type 2 Consumption (2017-2022)
-
7.5 Japan Neuropeptide Y Receptor Type 2 Consumption (2017-2022)
-
7.6 India Neuropeptide Y Receptor Type 2 Consumption (2017-2022)
-
7.7 South Korea Neuropeptide Y Receptor Type 2 Consumption (2017-2022)
8 Region and Country-wise Neuropeptide Y Receptor Type 2 Market Analysis and Outlook to 2028
-
8.1 Global Neuropeptide Y Receptor Type 2 Consumption Forecast (2022-2028)
-
8.2 United States Neuropeptide Y Receptor Type 2 Consumption Forecast (2022-2028)
-
8.3 Europe Neuropeptide Y Receptor Type 2 Consumption Forecast (2022-2028)
-
8.4 China Neuropeptide Y Receptor Type 2 Consumption Forecast (2022-2028)
-
8.5 Japan Neuropeptide Y Receptor Type 2 Consumption Forecast (2022-2028)
-
8.6 India Neuropeptide Y Receptor Type 2 Consumption Forecast (2022-2028)
-
8.7 South Korea Neuropeptide Y Receptor Type 2 Consumption Forecast (2022-2028)
9 Global Neuropeptide Y Receptor Type 2 Market Outlook by Types and Applications to 2022
-
9.1 Global Neuropeptide Y Receptor Type 2 Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global XL-310 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global NN-9748 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global GT-002 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Neuropeptide Y Receptor Type 2 Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Obesity Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Epilepsy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Neuropeptide Y Receptor Type 2 Market Outlook by Types and Applications to 2028
-
10.1 Global Neuropeptide Y Receptor Type 2 Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global XL-310 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global NN-9748 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global GT-002 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neuropeptide Y Receptor Type 2 Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Obesity Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Neuropeptide Y Receptor Type 2 Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neuropeptide Y Receptor Type 2 Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neuropeptide Y Receptor Type 2 Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neuropeptide Y Receptor Type 2 Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neuropeptide Y Receptor Type 2 Market Competitive Analysis
-
14.1 XL-protein GmbH
-
14.1.1 XL-protein GmbH Company Details
-
14.1.2 XL-protein GmbH Neuropeptide Y Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 XL-protein GmbH Neuropeptide Y Receptor Type 2 Product and Service
-
14.2 Gila Therapeutics Inc
-
14.2.1 Gila Therapeutics Inc Company Details
-
14.2.2 Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Product and Service
-
14.3 Novo Nordisk A/S
-
14.3.1 Novo Nordisk A/S Company Details
-
14.3.2 Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neuropeptide Y Receptor Type 2
-
Figure Neuropeptide Y Receptor Type 2 Picture
-
Table Global Neuropeptide Y Receptor Type 2 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuropeptide Y Receptor Type 2 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuropeptide Y Receptor Type 2 Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neuropeptide Y Receptor Type 2 Consumption by Country (2017-2022)
-
Figure United States Neuropeptide Y Receptor Type 2 Consumption and Growth Rate (2017-2022)
-
Table Europe Neuropeptide Y Receptor Type 2 Consumption and Growth Rate (2017-2022)
-
Figure China Neuropeptide Y Receptor Type 2 Consumption and Growth Rate (2017-2022)
-
Figure Japan Neuropeptide Y Receptor Type 2 Consumption and Growth Rate (2017-2022)
-
Figure India Neuropeptide Y Receptor Type 2 Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neuropeptide Y Receptor Type 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Neuropeptide Y Receptor Type 2 Consumption Forecast by Country (2022-2028)
-
Figure United States Neuropeptide Y Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neuropeptide Y Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neuropeptide Y Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neuropeptide Y Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neuropeptide Y Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neuropeptide Y Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global XL-310 Consumption and Growth Rate (2017-2022)
-
Figure Global NN-9748 Consumption and Growth Rate (2017-2022)
-
Figure Global GT-002 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Obesity Consumption and Growth Rate (2017-2022)
-
Figure Global Epilepsy Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global XL-310 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NN-9748 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GT-002 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Obesity Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neuropeptide Y Receptor Type 2 Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neuropeptide Y Receptor Type 2 Export by Region (Top 5 Countries) (2017-2028)
-
Table XL-protein GmbH (Foundation Year, Company Profile and etc.)
-
Table XL-protein GmbH Neuropeptide Y Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table XL-protein GmbH Neuropeptide Y Receptor Type 2 Product and Service
-
Table Gila Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Product and Service
-
Table Novo Nordisk A/S (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Product and Service
-
